A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog β-methyl-6-chloromelatonin
Year: 2004
Type: article
Study design: Clinical Trial
Source: Life Sciences
Authors: J.J Mulchahey, D.R Goldwater, F.P Zemlan
Institution: Bioanalytical Systems (United States)
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
Award: G1109984879
OpenAlex ID: W1983606133
